Clik here to view.
Study on Abdominal Surgical Patients Investigates Clinical Utility of Masimo...
IRVINE, Calif. Masimo (NASDAQ: MASI) announced today the findings of a study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong. In the study, researchers at Cairo...
View ArticleClik here to view.
Dr. Reddy’s Expands Strategic Collaboration with Amgen in India
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has expanded its strategic collaboration with Amgen, one of the world’s leading...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
第2回グローバルNCDアライアンス・フォーラム、2017年12月にUAEのシャルジャで開催へ
ニューヨーク （ビジネスワイヤ） — NCDアライアンスは昨晩、第2回グローバルNCDアライアンス・フォーラムを2017年12月9～11日にアラブ首長国連邦（UAE）のシャルジャで開催すると発表しました。 このSmart News Release（スマート・ニュース・リリース）にはマルチメディアのコンテンツが含まれています。リリース全文はこちらから：...
View ArticleClik here to view.
第二届全球NCD联盟论坛将于2017年12月在阿联酋沙迦召开
纽约 (美国商业资讯) — 非传染性疾病联盟（以下简称“NCD联盟”）昨晚宣布，第二届全球NCD联盟论坛将于2017年12月9-11日在阿拉伯联合酋长国(UAE)沙迦召开。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿： http://www.businesswire.com/news/home/20160920005830/zh-CN/...
View ArticleClik here to view.
GORE® TAG®胸主动脉血管内覆膜支架的枢纽性研究完成首例植入
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天宣布，GORE® TAG®胸主动脉血管内覆膜支架(TBE)的枢纽性研究完成首例植入。入组该例患者的是Himanshu Patel, MD，他是密西根大学佛兰克尔心血管中心成人心脏外科的分科主任和该研究的联席全国主要研究者。 Smart News...
View ArticleClik here to view.
One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN®...
FLAGSTAFF, Ariz. & LAS VEGAS W. L. Gore & Associates, Inc. (Gore) today announced positive results from a prospective, multicenter Investigational Device Exemption (IDE) Clinical Study of...
View ArticleClik here to view.
GORE® VIABAHN® Endoprosthesisが複雑なSFA疾患の治療で最適なデバイスであることを日本での臨床研究の1年成績が確認
米アリゾナ州フラッグスタッフ & ラスベガス （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、GORE® VIABAHN® Endoprosthesis with Heparin Bioactive...
View ArticleClik here to view.
日本临床研究1年结果证实，GORE® VIABAHN®血管内覆膜支架是治疗SFA复杂型病变的首选器械
亚利桑那州弗拉格斯塔夫和拉斯维加斯 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天发布了配备肝素生物活性涂层*的GORE®...
View ArticleClik here to view.
Acelity Announces Early Tender Results for the Exchange Offer and Successful...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, today announced the results, as of 5:00 p.m., New York City time, on September 19, 2016...
View ArticleClik here to view.
Takeda and Affilogic enter into Research Collaboration to Develop...
OSAKA, Japan & NANTES, France Takeda Pharmaceutical Company Limited (TSE: 4502) and Affilogic today jointly announced that the companies have entered into a research collaboration to explore...
View ArticleClik here to view.
GORE® TAG® Thoracic Branch Endoprosthesisのピボタル試験で初の植え込みが完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、ピボタル試験でGORE® TAG® Thoracic Branch...
View ArticleClik here to view.
SanBio Begins Clinical Trial of Regenerative Cell Medicine for Patients with...
MOUNTAIN VIEW, Calif. SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, announced today that it has begun a Phase 2 clinical trial of regenerative cell...
View ArticleClik here to view.
Gyros Protein Technologies Establishes Dedicated Office in Japan
UPPSALA, Sweden Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has established a...
View ArticleClik here to view.
GE Healthcare Aims to Fund up to $50M for Global Health Startups
BANGALORE, India GE Healthcare, the $18 billion healthcare technology division of GE (NYSE: GE), today announced the launch of the company’s first healthcare accelerator, five.eight, aimed at...
View ArticleClik here to view.
Exelixis Announces Collaborator Daiichi Sankyo’s Initiation of Phase 3...
SOUTH SAN FRANCISCO, Calif. Exelixis, Inc. (NASDAQ:EXEL) today announced that its partner Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has initiated a phase 3 pivotal trial to...
View ArticleClik here to view.
ジャイロス・プロテイン・テクノロジーズ、日本に専用オフィスを設立
スウェーデン・ウプサラ （ビジネスワイヤ） — ナノリットルスケール・イムノアッセイ装置自動化の先駆者であり、ペプチドシンセサイザーおよびペプチド試薬のリーディングプロバイダーであるジャイロス・プロテイン・テクノロジーズは本日、日本の東京に専用オフィスを開設し、ジャイロス・ジャパン株式会社を設立したと発表しました。...
View ArticleClik here to view.
First Patient Dosed in CANbridge’s CAN-008 Phase I/II Trial in...
BEIJING CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that the first patient was dosed in the Phase I/II trial...
View ArticleClik here to view.
武田薬品とアフィロジックが研究提携契約を締結し、Nanofitin®を使用して中枢神経系疾患の治療薬開発に当たる
大阪 & 仏ナント — （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
New Standards for Forensic Grade Manufacturing Integrated At Promega
MADISON, Wis. With recent approval in meeting the new ISO 18385 standard, Promega Corporation will be including a “Forensic Grade” classification on products used for human identity by crime labs,...
View Article